Sale!

Biopsy Breast Modified Radical Mastectomy and ER, PR, HER2NEU Test Cost

Original price was: 2,200 د.إ.Current price is: 1,650 د.إ.

-25%

A Biopsy Breast Modified Radical Mastectomy is a comprehensive surgical procedure aimed at treating breast cancer by removing the entire breast along with the lymph nodes in the axilla (underarm area), while preserving the pectoral muscles. This operation is often recommended when the cancer is too extensive for a lumpectomy (removal of the tumor and a small margin of surrounding tissue) but where the preservation of the chest muscles is still possible, helping to maintain a better post-surgical cosmetic outcome and potentially reducing recovery time.

Following the surgical procedure, the extracted tissue is typically analyzed to assess the presence and extent of cancer. This is where tests such as ER (Estrogen Receptor), PR (Progesterone Receptor), and HER2/neu come into play. These tests are crucial in determining the cancer’s characteristics, including its responsiveness to hormonal therapies and targeted treatments.

– **ER and PR Tests:** These tests measure the presence of estrogen and progesterone receptors in the cancer tissue. Cancers that are positive for these receptors (ER+ or PR+) are likely to respond to hormonal therapies, which can be an effective part of the treatment plan.

– **HER2/neu Test:** This test identifies the presence of the HER2 protein on the surface of the cancer cells. HER2-positive cancers are more aggressive but may respond well to targeted therapies designed to inhibit the HER2 protein.

At DNA Labs UAE, the cost for conducting the ER, PR, HER2/neu tests is 1650 AED. These tests are crucial for tailoring the most effective treatment plan post-mastectomy, offering a personalized approach to breast cancer care. DNA Labs UAE is equipped with state-of-the-art facilities and experienced professionals to ensure accurate and reliable test results, aiding in the optimal management and treatment of breast cancer.

Description

BIOPSY BREAST MODIFIED RADICALMASTECTOMY and ER and PR and HER2NEU Test

Test Name: BIOPSY BREAST MODIFIED RADICALMASTECTOMY and ER and PR and HER2NEU Test

Components: Tissue in 10% Neutral Buffered Formalin

Price: 1650.0 AED

Sample Condition: Tissue

Report Delivery: 6 days

Method: Histopathology

Test type: Genetics

Doctor: General Surgeon

Test Department:

Pre Test Information: BIOPSY BREAST (MODIFIED RADICALMASTECTOMY) +ER+PR+HER2NEU) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details:

A biopsy is a medical procedure where a small sample of tissue is taken from the body to be examined under a microscope. In this case, the biopsy is being done on the breast. Modified radical mastectomy is a surgical procedure where the entire breast tissue, including the breast gland, nipple, and some of the lymph nodes in the armpit area, are removed. This is usually done to treat breast cancer.

The notation ER+PR+HER2NEU refers to the results of a biopsy or testing of the breast tissue. ER stands for estrogen receptor, PR stands for progesterone receptor, and HER2NEU refers to the human epidermal growth factor receptor 2. These are proteins that can be present in breast cancer cells and can help determine the treatment options and prognosis of the disease.

A positive result for ER and PR means that the breast cancer cells have receptors for estrogen and progesterone, respectively. This indicates that hormone therapy, such as tamoxifen or aromatase inhibitors, may be effective in treating the cancer. A positive result for HER2NEU means that the breast cancer cells have an overexpression or amplification of the HER2NEU gene. This indicates that targeted therapies, such as trastuzumab (Herceptin), may be effective in treating the cancer.

Overall, the information provided suggests that the biopsy results show a breast cancer that is positive for estrogen receptor, progesterone receptor, and HER2NEU. This information will be important for determining the most appropriate treatment options for the individual.

Test Name	BIOPSY BREAST MODIFIED RADICALMASTECTOMY andERandPRandHER2NEU Test
Components	Tissue in 10% Neutral Buffered Formalin
Price	1650.0 AED
Sample Condition	Tissue
Report Delivery	6 days
Method	Histopathology
Test type	Genetics
Doctor	General Surgeon
Test Department:
Pre Test Information	BIOPSY BREAST (MODIFIED RADICALMASTECTOMY) +ER+PR+HER2NEU) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details	A biopsy is a medical procedure where a small sample of tissue is taken from the body to be examined under a microscope. In this case, the biopsy is being done on the breast. Modified radical mastectomy is a surgical procedure where the entire breast tissue, including the breast gland, nipple, and some of the lymph nodes in the armpit area, are removed. This is usually done to treat breast cancer. The notation ER+PR+HER2NEU refers to the results of a biopsy or testing of the breast tissue. ER stands for estrogen receptor, PR stands for progesterone receptor, and HER2NEU refers to the human epidermal growth factor receptor 2. These are proteins that can be present in breast cancer cells and can help determine the treatment options and prognosis of the disease. A positive result for ER and PR means that the breast cancer cells have receptors for estrogen and progesterone, respectively. This indicates that hormone therapy, such as tamoxifen or aromatase inhibitors, may be effective in treating the cancer. A positive result for HER2NEU means that the breast cancer cells have an overexpression or amplification of the HER2NEU gene. This indicates that targeted therapies, such as trastuzumab (Herceptin), may be effective in treating the cancer. Overall, the information provided suggests that the biopsy results show a breast cancer that is positive for estrogen receptor, progesterone receptor, and HER2NEU. This information will be important for determining the most appropriate treatment options for the individual.